Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@jax.org
Therapy Name | SL0101 |
Synonyms | |
Therapy Description |
SL0101 is an allosteric inhibitor of the N-terminal kinase domain of RSK1/2, which potentially results in reduced tumor cell proliferation (PMID: 27528706, PMID: 31513822). |
Drug Name | Trade Name | Synonyms | Drug Classes | Drug Description |
---|---|---|---|---|
SL0101 | SL-0101|SL 0101 | SL0101 is an allosteric inhibitor of the N-terminal kinase domain of RSK1/2, which potentially results in reduced tumor cell proliferation (PMID: 27528706, PMID: 31513822). |
Molecular Profile | Indication/Tumor Type | Response Type | Therapy Name | Approval Status | Evidence Type | Efficacy Evidence | References |
---|
Clinical Trial | Phase | Therapies | Title | Recruitment Status | Covered Countries | Other Countries |
---|